Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42:2668-2669,2670, Lyden, P.D., 2011
Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Stroke 42:2515-2520, Zinkstok, S.M.,et al, 2011
Lumbar Puncture in Paediatric Stroke
Lancet 378:848, Neuteboom, R.F.,et al, 2011
Stroke Recurrence within the Time Window Recommended for Carotid Endarterectomy
Neurol 77:738-743, Marrane, M.,et al, 2011
Helicopter Transport of Stroke Patients and Its Influence on Thrombolysis Rates
Stroke 42:1295-1300, Reiner-Deitemyer, V.,et al, 2011
Etiology of cervical artery dissections
Neurol 76:1452-1453, Schievink, W.I., & Debette, S., 2011
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011
Frontotemporal brain sagging syndrome
Neurol 76:1377-1382, Wicklund, M.R.,et al, 2011
Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011
Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase
BMJ 342:d1938, McArthur, K.S.,et al, 2011
Anticoagulation in Patients with Stroke With Infective Edocarditis Is Safe
Stroke 42:1795-1796,1799, Rasmussen, R.V., 2011
Anticoagulation Should Not Be Used in Most Patients With Stroke With Infective Endocarditis
Stroke 42:1797-1798,1799, Sila, C., 2011
Stenting versus Medical Treatment for Severe Symptomatic Intracranial Stenosis
AJNR 32:911-16, Tang, C.W.,et al, 2011
Multimodal Imaging Does Not Delay Intravenous Thrombolytic Therapy in Acute Stroke
AJNR 32:864-68, Salottolo, K.M.,et al, 2011
Is It Possible to Recognize Cervical Artery Dissection on Stroke Brain MR Imaging? A Matched Case-Control Study
AJNR 32:869-73, Naggara, O., et al, 2011
Role of Brain Imaging in Early Parkinsonism
BMJ 324:d638, Breen,D.P.,et al, 2011
Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011
Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality
JAMA 305:373-380, Xian,Y.,et al, 2011
Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting
JAMA 305:381-390, Tarakji,K.G.,et al, 2011
Hemicraniectomy in Malignant Middle Cerebral Artery Infarction
Stroke 42:513-516, Staykov,D. &Gupta,R., 2011
Hemorrhagic Transformation of Childhood Arterial Ischemic Stroke
Stroke 42:941-946, Beslow,L.A.,et al, 2011
Restenosis After Carotid Surgery: The Importance of Clinical Presentation and Preoperative Timing
Stroke 42:965-971, van Lammeren,G.W.,et al, 2011
Bridging Intravenous-Inta-Arterial Rescue Strategy Increases Recanalization and the Likelihood of a Good Outcome in Nonresponder Intravenous Tissue Plasminogen Activator-Treated Patients: A Case-Control Study
Stroke 42:993-997, 880, Rubiera,M.,et al, 2011
Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011
Revascularization of Asymptomatic High-Grade Carotid Stenosis Is Still Indicated in Some Cases
Stroke 42:1152-1153, 1156, Markus,H., 2011
Revascularization of Asymptomatic High-Grade Stenosis Is Not Indicated With Contemporary Stroke Prevention Medical Therapy
Stroke 42:1154-1155, 1156, Ingall,T.J., 2011
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Computed Tomographic Angiography and Venography for Young or Nonhypertensive Patients With Acute Spontaneous Intracerebral Hemorrhage
Stroke 42:211-213, Wong,G.K.C.,et al, 2011
Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011
Pearls & Oy-sters: Reversible Cerebral Vasoconstriction Syndrome Precipitated by Ascent to High Altitude
Neurol 76:e7-e9, Neil,W.P.,et al, 2011
Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011
Percutaneous Vascular Interventions for Acute Ischemic Stroke
Stroke 42:e31-e32, ORourke,K.,et al, 2011
Early Decompressive Hemicraniectomy in Older Patients With Nondominant Hemispheric Infarction Does Not Improve Outcome
Stroke 42:845-846, 847, van der Worp,H.B. &Kappelle,L.J., 2011
Early Decompressive Hemicraniectomy in Older Patients With Nondominant Hemispheric Infarction Improves Outcome
Stroke 42:843-844, 847, J�ttler,E. &Hacke,W., 2011
Personalized Approaches to Clopidogrel Therapy: Are We There Yet?
Stroke 41:2997-3002, Anderson,C.D.,et al, 2010
Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010
Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy
Stroke 41:2775-2781, Shi,Z.-S.,et al, 2010
Licorice-Associated Reversible Cerebral Vasoconstriction With PRES
Neurol 75:1939-1941, Chatterjee,N.,et al, 2010
Cost-Effectiveness of Multimodal CT for Evaluation Acute Stroke
Neurol 75:1678-1685, Young,K.C.,et al, 2010
Brain Biopsy in Children With Primary Small-Vessel Central Nervous System Vasculitis
Ann Neurol 68:602-610, 573, Elbers,J.,et al, 2010
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Stroke 41:2860-2866, Majeed,A.,et al, 2010
No-Go to Tissue Plasminogen Activator for Transient Ischemic Attack
Stroke 41:3005-3006, 3007, Liebeskind,D.S., 2010
Pro: Intravenous Tissue Plasminogen Activator in Stroke Patients With Rapid, Complete Recovery During Evaluation (Transient Ischemic Attack) and Evidence of Middle Cerebral Artery Occlusion
Stroke 41:3003-3004, 3007, K�hrmann,M. &Schellinger,P.D., 2010
Dabigatran Etexilate - A Novel, Reversible, Oral Direct Thrombin Inhibitor: Interpretation of Coagulation Assays and Reversal of Anticoagulant Activity
Thromb Hemost 103:1116-1127, van Ryn,J.,et al, 2010
Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010
Hemichorea-Hemiballism after Diabetic Ketoacidosis
NEJM 363:e27, Duker,A.P. &Epsay,A.J., 2010
Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010
Prescribing Antiplatelet Medicine and Subsequent Events After Intracerebral Hemorrhage
Stroke 41:2606-2611, Flynn,R.W.V.,et al, 2010